Literature DB >> 29478037

Response to: 'Congenital tricuspid valve disease can masquerade as primary idiopathic TR' by Rajpal.

Erin Amanda Fender1, Chad J Zack1, Rick A Nishimura1.   

Abstract

Entities:  

Keywords:  cardiac surgery; tricuspid valve disease

Mesh:

Year:  2018        PMID: 29478037      PMCID: PMC6204973          DOI: 10.1136/heartjnl-2018-313078

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
We received the letter by Dr Rajpal  addressing the spectrum of congenital tricuspid valve (TV) abnormalities and highlighting congenital tricuspid disease as an under-recognised cause of isolated tricuspid regurgitation (TR) in adults. We agree wholeheartedly that there is a wide spectrum of congenital tricuspid valve disease, ranging from Ebstein’s anomaly to tricuspid valve dysplasia which encompasses both primary leaflet malformations and chordal abnormalities. While Ebstein’s anomaly is a well-recognised cause of primary tricuspid regurgitation, isolated tricuspid valve dysplasia is less frequently encountered in adults without other associated congenital abnormalities.1 The rarity of isolated TV dysplasia, coupled with the technical difficulties of imaging the tricuspid valve, makes this a challenging diagnosis. In our own practice we have encountered several patients with severe isolated TR who were referred to surgery and were found intraoperatively to have previously unrecognised leaflet dysplasia. A low index of suspicion must be maintained in relatively young adults presenting with isolated tricuspid regurgitation in the absence of other potential causes, particularly as surgery has proven efficacy in treating these patients.2 3
  3 in total

1.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

2.  Management of tricuspid regurgitation in congenital heart disease: is survival better with valve repair?

Authors:  Sameh M Said; Joseph A Dearani; Harold M Burkhart; Heidi M Connolly; Ben Eidem; Paul E Stensrud; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-29       Impact factor: 5.209

Review 3.  Isolated tricuspid regurgitation: outcomes and therapeutic interventions.

Authors:  Erin A Fender; Chad J Zack; Rick A Nishimura
Journal:  Heart       Date:  2017-12-11       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.